Cerba injects €365m into high yield bond market
Cerba European Lab, the French operator of clinical pathology laboratories owned by PAI Partners, sold its high yield debut bond increased and at the tight guidance on Friday.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts